Most cited papers from Texas Neurology

Texas Neurology

What are the most cited papers from Texas Neurology?

The most cited paper from Texas Neurology is "Glioma stem cells promote radioresistance by preferential activation of the DNA damage response" (Shideng Bao, Qiulian Wu, Roger E. McLendon et al., 2006), with 6,478 citations. Next come "A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis" (3,396) and "Stem Cell–like Glioma Cells Promote Tumor Angiogenesis through Vascular Endothelial Growth Factor" (1,352).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 60 papers. Every paper with more than 67 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Glioma stem cells promote radioresistance by preferential activation of the DNA damage response Shideng Bao, Qiulian Wu, Roger E. McLendon et al. · Nature	18 Oct 2006	6,478
2	A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis Chris H. Polman, Paul W O'Connor, Eva Havrdová et al. · New England Journal of Medicine Open access	Mar 2006	3,396
3	Stem Cell–like Glioma Cells Promote Tumor Angiogenesis through Vascular Endothelial Growth Factor Shideng Bao, Qiulian Wu, Sith Sathornsumetee et al. · Cancer Research	15 Aug 2006	1,352
4	Recurrent Glioblastoma Treated with Recombinant Poliovirus Annick Desjardins, Matthias Gromeier, James E. Herndon et al. · New England Journal of Medicine Open access	26 Jun 2018	821
5	Trial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral Sclerosis Sabrina Paganoni et al. · New England Journal of Medicine Open access	2 Sep 2020	542
6	Adjunctive perampanel for refractory partial-onset seizures Jacqueline A. French et al. · Neurology Open access	27 Jul 2012	480
7	Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study Eva Havrdová, Steven L. Galetta, Michael Hutchinson et al. · The Lancet Neurology	8 Feb 2009	478
8	Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome Zachary J. Reitman, Genglin Jin, Edward D. Karoly et al. · Proceedings of the National Academy of Sciences Open access	2 Feb 2011	461
9	Immune surveillance in multiple sclerosis patients treated with natalizumab Olaf Stüve, Christina M. Marra, Keith R. Jerome et al. · Annals of Neurology	21 Apr 2006	438
10	Proteomic and immunologic analyses of brain tumor exosomes Michael W. Graner, Óscar Álzate, Angelika M. Dechkovskaia et al. · The FASEB Journal Open access	24 Dec 2008	429
11	Adult degenerative scoliosis: evaluation and management Fernando E. Silva, Lawrence G. Lenke · Neurosurgical FOCUS Open access	Mar 2010	382
12	The incidence and significance of anti-natalizumab antibodies Peter A. Calabresi, Gavin Giovannoni, Christian Confavreux et al. · Neurology	30 Aug 2007	334
13	Factors that influence adherence with disease-modifying therapy in MS Katherine Treadaway et al. · Journal of Neurology	Apr 2009	258
14	The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL for the AFFIRM and SENTINEL Investigators et al. · Journal of Neurology Open access	Mar 2009	235
15	Mechanism of action of mitoxantrone Edward Fox · Neurology	28 Dec 2004	215
16	Treatment of hyperphosphatemia in hemodialysis patients: The Calcium Acetate Renagel Evaluation (CARE Study) Wajeh Y. Qunibi, Robert E. Hootkins, Laveta L. McDowell et al. · Kidney International Open access	13 Apr 2004	214
17	Predictors of a child's ability to use a visual analogue scale Brenda J. Shields, Tonya Mizell Palermo, Jean D. Powers et al. · Child Care Health and Development	19 Jun 2003	198
18	Phase I Trial of “bi-shRNAifurin/GMCSF DNA/Autologous Tumor Cell” Vaccine (FANG) in Advanced Cancer Neil N. Senzer et al. · Molecular Therapy Open access	20 Dec 2011	198
19	Health‐related quality of life in multiple sclerosis: effects of natalizumab Richard A. Rudick et al. · Annals of Neurology	14 Aug 2007	195
20	A novel low‐molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth Qing Shi, Anita B. Hjelmeland, Stephen Thomas Keir et al. · Molecular Carcinogenesis	11 Jan 2007	191
21	Expanded Clinical Phenotype, Oncological Associations, and Immunopathologic Insights of Paraneoplastic Kelch-like Protein-11 Encephalitis Divyanshu Dubey et al. · JAMA Neurology Open access	3 Aug 2020	186
22	Long‐term survival of participants in the CENTAUR trial of sodium phenylbutyrate‐taurursodiol in amyotrophic lateral sclerosis Sabrina Paganoni et al. · Muscle & Nerve Open access	16 Oct 2020	185
23	Predictors of outcome in prolonged posttraumatic disorders of consciousness and assessment of medication effects: A multicenter study John Whyte, Douglas I. Katz, David Nicholas Long et al. · Archives of Physical Medicine and Rehabilitation	Mar 2005	177
24	Answer ALS, a large-scale resource for sporadic and familial ALS combining clinical and multi-omics data from induced pluripotent cell lines Emily G. Baxi et al. · Nature Neuroscience Open access101 authors	Feb 2022	162
25	The Community Collaborative Rain, Hail, and Snow Network: Informal Education for Scientists and Citizens Robert C. Cifelli, Nolan J. Doesken, Patrick C. Kennedy et al. · Bulletin of the American Meteorological Society Open access	Aug 2005	150
26	Multi-Biosignal Analysis for Epileptic Seizure Monitoring Diana Cogan, Javad Birjandtalab, Mehrdad Nourani et al. · International Journal of Neural Systems	7 Apr 2016	128
27	Multiple sclerosis patients—benefit-risk preferences: Serious adverse event risks versus treatment efficacy F. Reed Johnson, George Van Houtven, Semra Özdemir et al. · Journal of Neurology	Apr 2009	125
28	Quality of life in pediatric epilepsy: demographic and disease-related predictors and comparison with healthy controls Victoria Miller, Tonya Mizell Palermo, Scott D. Grewe · Epilepsy & Behavior	Feb 2003	123
29	Embedded Symptom Validity Tests and Overall Neuropsychological Test Performance John E. Meyers, Marie E. Volbrecht, B. N. Axelrod et al. · Archives of Clinical Neuropsychology	17 Jan 2011	119
30	Monoclonal antibody blockade of IL-2 receptor α during lymphopenia selectively depletes regulatory T cells in mice and humans Duane A. Mitchell, Xiuyu Cui, Robert J. Schmittling et al. · Blood Open access	19 Jul 2011	115
31	Analysis of Varicella-Zoster Virus in Temporal Arteries Biopsy Positive and Negative for Giant Cell Arteritis Maria A. Nagel et al. · JAMA Neurology Open access	8 Sep 2015	114
32	Multicenter phase III trial studying trospium chloride in patients with overactive bladder Delbert C. Rudy, Kevin J. Cline, Richard Edmund Harris et al. · Urology	Feb 2006	112
33	Estimated Costs of Malingered Disability Michael D. Chafetz, James Underhill · Archives of Clinical Neuropsychology	25 Jun 2013	110
34	Shear-Induced Platelet Aggregation in Normal Subjects and Stroke Patients Konstantinos Konstantopoulos, James Charles Grotta, Cynthia Sills et al. · Thrombosis and Haemostasis	1995	109
35	Frameless robot-assisted stereoelectroencephalography in children: technical aspects and comparison with Talairach frame technique Taylor J. Abel, René Varela Osorio, Ricardo Amorim-Leite et al. · Journal of Neurosurgery Pediatrics Open access	20 Apr 2018	107
36	Global identification of MLL2-targeted loci reveals MLL2’s role in diverse signaling pathways Changcun Guo, Chun-Chi Chang, Matthew Wortham et al. · Proceedings of the National Academy of Sciences Open access	8 Oct 2012	104
37	The Kerr–de Sitter universe Sarp Akçay, Richard A. Matzner · Classical and Quantum Gravity Open access	28 Mar 2011	104
38	Sustained improvement in Expanded Disability Status Scale as a new efficacy measure of neurological change in multiple sclerosis: treatment effects with natalizumab in patients with relapsing multiple sclerosis J. Theodore Phillips, Gavin Giovannoni, FRED D. LUBLIN et al. · Multiple Sclerosis Journal	18 Mar 2011	102
39	Rey-Auditory Verbal Learning and Rey-Osterrieth Complex Figure Design performance in Alzheimer's disease and closed head injury Erin D. Bigler, Lisa Rosa, Frank W. Schultz et al. · Journal of Clinical Psychology	Mar 1989	101
40	The Brain Health Imperative in the 21st Century—A Call to Action Natalia S. Rost, Joel Salinas, Justin T. Jordan et al. · Neurology Open access	20 Sep 2023	100
41	Management of worsening multiple sclerosis with mitoxantrone: A review Edward Fox · Clinical Therapeutics	Apr 2006	100
42	Heptanoate as a Neural Fuel: Energetic and Neurotransmitter Precursors in Normal and Glucose Transporter I-Deficient (G1D) Brain Isaac Marin‐Valencia, Levi B. Good, Qian Ma et al. · Journal of Cerebral Blood Flow & Metabolism Open access	17 Oct 2012	100
43	Ocrelizumab infusion experience in patients with relapsing and primary progressive multiple sclerosis: Results from the phase 3 randomized OPERA I, OPERA II, and ORATORIO studies Lori Mayer, Ludwig Kappos, Michael K. Racke et al. · Multiple Sclerosis and Related Disorders Open access	29 Jan 2019	99
44	Long-term results of posteromedial hypothalamic deep brain stimulation for patients with resistant aggressiveness Cristina V. Torres, Rafael García de Sola, Jesús Pastor et al. · Journal of neurosurgery	7 Jun 2013	99
45	Sleep polysomnography as a predictor of recurrence in children and adolescents with major depressive disorder Graham J. Emslie, Roseanne Armitage, Warren A. Weinberg et al. · The International Journal of Neuropsychopharmacology Open access	Jun 2001	94
46	Genucom, KT-1000, and Stryker knee laxity measuring device comparisons Carl L. Highgenboten, Allen Jackson, Neil B. Meske · The American Journal of Sports Medicine	Nov 1989	93
47	Magnetic Resonance Imaging of Diffuse Axonal Injury: Quantitative Assessment of White Matter Lesion Volume Carlos Marquez de la Plata, Andreea Ardelean, Della Koovakkattu et al. · Journal of Neurotrauma	Apr 2007	93
48	Primary hypospadias repair techniques: A review of the evidence WARREN T. SNODGRASS, Nicol Corbin Bush · Urology Annals Open access	2016	90
49	miR-33a promotes glioma-initiating cell self-renewal via PKA and NOTCH pathways Hui Wang, Tao Sun, Jing Ying Hu et al. · Journal of Clinical Investigation Open access	8 Sep 2014	90
50	Predictors of short-term outcome in brain-injured patients with disorders of consciousness John Whyte, Olivia Gosseries, Inna Chervoneva et al. · Progress in brain research Book chapterOpen access	2009	85

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.